Intrinsic Value of S&P & Nasdaq Contact Us

Rite Aid Corporation RAD NYSE

NYSE • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score
36/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.00
+979.7%

Rite Aid Corporation (RAD) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is neutral — 3 Buy, 4 Hold, 3 Sell.

The consensus price target is $7.00, representing an upside of 979.7% from the current price $0.65.

RAD Stock — 12-Month Price Forecast

$7.00
▲ +979.75% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Rite Aid Corporation, the price target is $7.00.
The average price target represents a +979.75% change from the last price of $0.65.

RAD Analyst Ratings

Hold
10
Ratings
3 Buy
4 Hold
3 Sell
Based on 10 analysts giving stock ratings to Rite Aid Corporation in the past 3 months
Rating breakdown
Buy
3 30%
Hold
4 40%
Sell
3 30%
30%
Buy
3 analysts
40%
Hold
4 analysts
30%
Sell
3 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message